Production of Pseudoinfectious Yellow Fever Virus with a Two-Component Genome
- 1 November 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (21) , 11737-11748
Abstract
Application of genetically modified, deficient-in-replication flaviviruses that are incapable of developing productive, spreading infection is a promising means of designing safe and effective vaccines. Here we describe a two-component genome yellow fever virus (YFV) replication system in which each of the genomes encodes complete sets of nonstructural proteins that form the replication complex but expresses either only capsid or prM/E instead of the entire structural polyprotein. Upon delivery to the same cell, these genomes produce together all of the viral structural proteins, and cells release a combination of virions with both types of genomes packaged into separate particles. In tissue culture, this modified YFV can be further passaged at an escalating scale by using a high multiplicity of infection (MOI). However, at a low MOI, only one of the genomes is delivered into the cells, and infection cannot spread. The replicating prM/E-encoding genome produces extracellular E protein in the form of secreted subviral particles that are known to be an effective immunogen. The presented strategy of developing viruses defective in replication might be applied to other flaviviruses, and these two-component genome viruses can be useful for diagnostic or vaccine applications, including the delivery and expression of heterologous genes. In addition, the achieved separation of the capsid-coding sequence and the cyclization signal in the YFV genome provides a new means for studying the mechanism of the flavivirus packaging process.Keywords
This publication has 39 references indexed in Scilit:
- Production and characterization of vaccines based on flaviviruses defective in replicationVirology, 2006
- Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis VirusJournal of Virology, 2005
- Noncytopathic Replication of Venezuelan Equine Encephalitis Virus and Eastern Equine Encephalitis Virus Replicons in Mammalian CellsJournal of Virology, 2005
- Sindbis Virus with a Tricomponent GenomeJournal of Virology, 2005
- Induction of Sterilizing Immunity against West Nile Virus (WNV), by Immunization with WNV‐Like Particles Produced in Insect CellsThe Journal of Infectious Diseases, 2004
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteinNature Biotechnology, 2004
- A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replicationJournal of General Virology, 2003
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in miceVaccine, 2000
- Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virusArchives of Virology, 1996